Published in Blood Weekly, December 20th, 2001
On behalf of the CRUISE study investigators, Deepak L. Bhatt, MD, an interventional cardiologist at the Cleveland Clinic Foundation, presented the results of the first randomized trial comparing enoxaparin and unfractionated heparin in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.